Is heel ultrasonography a good screening tool for bone loss after kidney and pancreas transplantation?
The QUS is an unacceptable tool for identifying those at risk for bone loss after kidney or pancreas transplantation.
Adiponectin through its biphasic serum level is a useful biomarker during transition from diastolic dysfunction to systolic dysfunction.